Market Cap : 968 M | Enterprise Value : 788.46 M | PE Ratio : | PB Ratio : 4.95 |
---|
NAS:GTHX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:GTHX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
G1 Therapeutics's quarterly additional paid-in capital increased from Jun. 2020 ($602.94 Mil) to Sep. 2020 ($608.24 Mil) and increased from Sep. 2020 ($608.24 Mil) to Dec. 2020 ($613.46 Mil).
G1 Therapeutics's annual additional paid-in capital increased from Dec. 2018 ($573.23 Mil) to Dec. 2019 ($592.38 Mil) and increased from Dec. 2019 ($592.38 Mil) to Dec. 2020 ($613.46 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.
Additional Paid-In Capital is calculated as
Additional Paid-In Capital | = | (Issue Price | - | Par Value) | * | Shares Outstanding (Diluted Average) |
No Headline